Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?

2018141 citationsReview

Authors

Good health and well-being

Published in: Drug Safety

Volume 41, Issue 7, pp. 645-653

Field-Weighted Citation Impact: 19.41